DNA & Genetics Lilly Inks Up to $11.25B in Cancer, Immune System DealsBy adminFebruary 11, 20260 Flush with cash from its obesity/diabetes dual blockbuster tirzepatide, Eli Lilly signaled earlier this month that it intended to invest…
